Company intelligence / Profile preview

Clearwater Bay Ventures

Ownership: Private
Development stage: Other

Overview

Clearwater Bay Ventures appears to be a private investment firm rather than an operating biotechnology, pharmaceutical, or healthcare company. Available evidence indicates the legal entity name is Clear Water Bay Ventures GmbH and that it has participated in at least one healthcare-related investment, including Rebeccatech's Series A+ financing. However, there is no clear evidence that Clearwater Bay Ventures itself develops therapeutics, runs a clinical pipeline, or operates as a biotech, pharma, CRO, or CDMO. It is best characterized as an investor with some exposure to healthcare or medtech deals.

Industry: Investors

Partnerships

Rebeccatech financing syndicate with Hillhouse Capital and Pechoin Fund

Beyond the preview

Go deeper on Clearwater Bay Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clearwater Bay Ventures.

Explore the full profile